{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:08:19Z","timestamp":1790100499141,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jns.2025.123400","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T08:23:39Z","timestamp":1737447819000},"page":"123400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["High prevalence of facioscapulohumeral muscular dystrophy (FSHD) and inflammatory myopathies association: Is there an interplay?"],"prefix":"10.1016","volume":"470","author":[{"given":"Antonio","family":"Lauletta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Allenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"B\u00e9hin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresinha","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"L\u00e9onard-Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Garibaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2025.123400_bb0005","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.bor.0000179948.65895.1a","article-title":"Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis","volume":"17","author":"Tidball","year":"2005","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jns.2025.123400_bb0010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/01.bor.0000179940.14109.50","article-title":"Autoimmune myositis: new concepts for disease initiation and propagation","volume":"17","author":"Casciola-Rosen","year":"2005","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jns.2025.123400_bb0015","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2025.123400_bb0020","article-title":"Immune-mediated necrotizing myopathy (IMNM): a myopathological challenge","author":"Merlonghi","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jns.2025.123400_bb0025","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy","volume":"201","author":"Casciola-Rosen","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jns.2025.123400_bb0030","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.24977","article-title":"Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle","volume":"60","author":"Mammen","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2025.123400_bb0035","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/art.38863","article-title":"Expression of the dermatomyositis autoantigen transcription intermediary factor 1\u03b3 in regenerating muscle","volume":"67","author":"Mohassel","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jns.2025.123400_bb0040","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1212\/WNL.0000000000004923","article-title":"Necrosis in anti-SRP+ and anti-HMGCR+myopathies: role of autoantibodies and complement","volume":"90","author":"Allenbach","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.123400_bb0045","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2025.123400_bb0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0959-437X(03)00048-0","article-title":"Muscular dystrophies: genes to pathogenesis","volume":"13","author":"Dalkilic","year":"2003","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.jns.2025.123400_bb0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00401-010-0727-5","article-title":"Muscular dystrophies: an update on pathology and diagnosis","volume":"120","author":"Sewry","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2025.123400_bb0060","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/j.lpm.2010.11.023","article-title":"Myositis or dystrophy? Traps and pitfalls","volume":"40","author":"Benveniste","year":"2011","journal-title":"Presse Med"},{"key":"10.1016\/j.jns.2025.123400_bb0065","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1002\/mus.880181312","article-title":"Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses","author":"Arahata","year":"1995","journal-title":"Muscle Nerve Suppl."},{"key":"10.1016\/j.jns.2025.123400_bb0070","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1212\/WNL.57.11.2136","article-title":"Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients","volume":"57","author":"Gallardo","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.123400_bb0075","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.nmd.2017.04.012","article-title":"Calpainopathy with macrophage-rich, regional inflammatory infiltrates","volume":"27","author":"Schutz","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2025.123400_bb0080","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.nmd.2009.11.005","article-title":"Two siblings with limb-girdle muscular dystrophy type 2E responsive to deflazacort","volume":"20","author":"Wong-Kisiel","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2025.123400_bb0085","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.nmd.2021.09.010","article-title":"Facioscapulohumeral muscular dystrophy type 2: an update on the clinical, genetic, and molecular findings","volume":"31","author":"Jia","year":"2021","journal-title":"Neuromuscul. Disord."},{"issue":"721\u20138","key":"10.1016\/j.jns.2025.123400_bb0090","first-page":"ix","article-title":"Facioscapulohumeral muscular dystrophy","volume":"32","author":"Statland","year":"2014","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.jns.2025.123400_bb0095","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/cge.13726","article-title":"Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy","volume":"97","author":"Greco","year":"2020","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jns.2025.123400_bb0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/cge.14466","article-title":"Characterization of D4Z4 alleles and assessment of de novo cases in Facioscapulohumeral dystrophy (FSHD) in a cohort of Italian families","volume":"105","author":"Strafella","year":"2024","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jns.2025.123400_bb0105","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/WCO.0000000000000855","article-title":"Where are we moving in the classification of idiopathic inflammatory myopathies?","volume":"33","author":"Tanboon","year":"2020","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jns.2025.123400_bb0110","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.nmd.2019.03.002","article-title":"1st ENMC European meeting: the EURO-NMD pathology working group recommended standards for muscle pathology Amsterdam, the Netherlands, 7 December 2018","volume":"29","author":"Udd","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2025.123400_bb0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40478-018-0655-5","article-title":"\u201cDusty core disease\u201d (DuCD): expanding morphological spectrum of RYR1 recessive myopathies","volume":"7","author":"Garibaldi","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jns.2025.123400_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102498","article-title":"Muscle involvement in myasthenia gravis: expanding the clinical spectrum of myasthenia-myositis association from a large cohort of patients","volume":"19","author":"Garibaldi","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"Suppl. 2","key":"10.1016\/j.jns.2025.123400_bb0125","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.nmd.2012.06.005","article-title":"Towards harmonization of protocols for MRI outcome measures in skeletal muscle studies: consensus recommendations from two TREAT-NMD NMR workshops, 2 may 2010, Stockholm, Sweden, 1-2 October 2009, Paris, France","volume":"22","author":"Hollingsworth","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jns.2025.123400_bb0130","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1007\/s00415-017-8498-8","article-title":"Muscle MRI in neutral lipid storage disease (NLSD)","volume":"264","author":"Garibaldi","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2025.123400_bb0135","doi-asserted-by":"crossref","first-page":"21648","DOI":"10.1038\/s41598-020-78578-7","article-title":"Large genotype\u2013phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis","volume":"10","author":"Ricci","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2025.123400_bb0140","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","article-title":"Incidence and prevalence of inflammatory myopathies: a systematic review","volume":"54","author":"Meyer","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.jns.2025.123400_bb0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/cge.14533","article-title":"Best practice guidelines on genetic diagnostics of facioscapulohumeral muscular dystrophy: update of the 2012 guidelines","volume":"106","author":"Giardina","year":"2024","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jns.2025.123400_bb0150","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/S2665-9913(20)30280-0","article-title":"Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial","volume":"3","author":"Benveniste","year":"2021","journal-title":"The Lancet Rheumatology"},{"key":"10.1016\/j.jns.2025.123400_bb0155","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/ana.20900","article-title":"Calpainopathy and eosinophilic myositis","volume":"59","author":"Brown","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2025.123400_bb0160","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1212\/01.wnl.0000287138.89373.6b","article-title":"Adults with eosinophilic myositis and calpain-3 mutations","volume":"70","author":"Amato","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.123400_bb0165","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1212\/WNL.0b013e3182a35285","article-title":"Diagnostic challenge and therapeutic dilemma in necrotizing myopathy","volume":"81","author":"Claeys","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.123400_bb0170","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000172","article-title":"Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease","volume":"2","author":"Mammen","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jns.2025.123400_bb0175","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/mus.24621","article-title":"Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies","volume":"52","author":"Statland","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2025.123400_bb0180","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1084\/jem.190.6.815","article-title":"Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity","volume":"190","author":"Casciola-Rosen","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jns.2025.123400_bb0185","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/1521-1878(200007)22:7<627::AID-BIES5>3.0.CO;2-K","article-title":"Cell death: a trigger of autoimmunity?","volume":"22","author":"Rodenburg","year":"2000","journal-title":"Bioessays"},{"key":"10.1016\/j.jns.2025.123400_bb0190","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.devcel.2019.08.010","article-title":"The good, the bad, and the unexpected: roles of DUX4 in health and disease","volume":"50","author":"Himeda","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jns.2025.123400_bb0195","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.3390\/cells10123322","article-title":"DUX4 role in Normal physiology and in FSHD muscular dystrophy","volume":"10","author":"Mocciaro","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jns.2025.123400_bb0200","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3233\/JND-210653","article-title":"Profiling serum antibodies against muscle antigens in Facioscapulohumeral muscular dystrophy finds no disease-specific autoantibodies","volume":"8","author":"Greco","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.jns.2025.123400_bb0205","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/BOR.0000000000000328","article-title":"New developments in genetics of myositis","volume":"28","author":"Rothwell","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jns.2025.123400_bb0210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrrheum.2018.48","article-title":"Risk factors and disease mechanisms in myositis","volume":"14","author":"Miller","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jns.2025.123400_bb0215","first-page":"75","article-title":"Triggers of inflammatory myopathy: insights into pathogenesis","volume":"25","author":"Adler","year":"2018","journal-title":"Discov. Med."},{"key":"10.1016\/j.jns.2025.123400_bb0220","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature05919","article-title":"Phenotypic plasticity and the epigenetics of human disease","volume":"447","author":"Feinberg","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jns.2025.123400_bb0225","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/hmg\/ddz239","article-title":"The variability of SMCHD1 gene in FSHD patients: evidence of new mutations","volume":"28","author":"Strafella","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jns.2025.123400_bb0230","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.gde.2015.08.007","article-title":"Genetic and epigenetic contributors to FSHD","volume":"33","author":"Daxinger","year":"2015","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.jns.2025.123400_bb0235","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10048-019-00575-4","article-title":"Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS era","volume":"20","author":"Zampatti","year":"2019","journal-title":"Neurogenetics"},{"key":"10.1016\/j.jns.2025.123400_bb0240","doi-asserted-by":"crossref","first-page":"e2273","DOI":"10.1212\/WNL.0000000000007456","article-title":"FSHD1 and FSHD2 form a disease continuum","volume":"92","author":"Sacconi","year":"2019","journal-title":"Neurology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25000176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25000176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T01:46:59Z","timestamp":1740102419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25000176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":48,"alternative-id":["S0022510X25000176"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123400","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High prevalence of facioscapulohumeral muscular dystrophy (FSHD) and inflammatory myopathies association: Is there an interplay?","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123400"}}